Verastem, Inc. (VSTM)
7.98
-0.04
(-0.50%)
USD |
NASDAQ |
Sep 03, 16:00
7.965
-0.02
(-0.19%)
After-Hours: 20:00
Verastem Net Income (Annual) : -209.47M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -209.47M |
| December 31, 2024 | -130.64M |
| December 31, 2023 | -87.37M |
| December 31, 2022 | -73.81M |
| December 31, 2021 | -71.20M |
| December 31, 2020 | -67.73M |
| December 31, 2019 | -149.21M |
| December 31, 2018 | -72.43M |
| Date | Value |
|---|---|
| December 31, 2017 | -67.80M |
| December 31, 2016 | -36.44M |
| December 31, 2015 | -57.86M |
| December 31, 2014 | -53.36M |
| December 31, 2013 | -41.20M |
| December 31, 2012 | -31.99M |
| December 31, 2011 | -13.72M |
| December 31, 2010 | -0.786M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 391.00M |
| Dianthus Therapeutics, Inc. | -162.34M |
| Alnylam Pharmaceuticals, Inc. | 313.75M |
| Anika Therapeutics, Inc. | -9.979M |
| Savara, Inc. | -118.84M |